Delivery Order SPE2DB22D1017-SPE2DB25FYQUS
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,389.64 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count) under a firm fixed price contract type. The award, made on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count units) under a firm fixed-price contract on July 2, 2025, with a ceiling value of $4,382.36 and an ultimate completion date of July 3, 2025. This award represents a non-competitive set-aside delivery order issued from AmerisourceBergen's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.99 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.58 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price delivery order issued without a set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $5,644.62, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order represents a standard pharmaceutical procurement transaction sourced from AmerisourceBergen's extensive federal contract portfolio. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.88 to AmerisourceBergen Drug Corp for Lamictal XR 300 mg tablets (quantity: 30-count packages) on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,432.53 on July 22, 2025, for Lamictal XR 250 mg tablets (30-count packages). The contract is a firm fixed price delivery order without set-aside designation, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Lamictal XR 25 mg tablets (30-count units) with a ceiling value of $4,524.46 and a firm fixed price structure. The delivery order, which is scheduled for completion by April 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026)....